Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Desflurane + nitrous oxide is a combination of two inhaled anesthetic agents commonly used for the induction and maintenance of general anesthesia during surgical procedures. Desflurane is a volatile halogenated ether anesthetic with rapid onset and offset due to its low blood-gas partition coefficient, making it suitable for both inpatient and outpatient surgeries. Nitrous oxide is a non-halogenated inhaled anesthetic gas that provides analgesic effects and enhances the potency of other volatile agents when used in combination. The mechanism of action for both drugs involves modulation of central nervous system activity by enhancing inhibitory neurotransmission (primarily via Gamma-aminobutyric acid type A receptor for desflurane) and inhibiting excitatory neurotransmission (notably through N-methyl-D-aspartate receptor antagonism by nitrous oxide). This results in hypnosis, amnesia, immobility, and analgesia[1][3][4][5][6]. The combination allows for lower doses of each agent while achieving effective anesthesia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on desflurane + nitrous oxide.